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Abstract: Novel three-dimensional (3D) nanohydroxyapatite-PLGA scaffolds with high porosity
was developed to better mimic mineral component and microstructure of natural bone. To perform
a final assessment of this nanomaterial as a potential bone substitute, its toxicological profile was
particularly investigated. Therefore, we performed a comet assay on human monocytes for in vitro
genotoxicity investigation, and the systemic subchronic toxicity investigation on rats being per
oral feed with exactly administrated extract quantities of the nano calcium hydroxyapatite covered
with tiny layers of PLGA (ALBO-OS) for 120 days. Histological and stereological parameters of
the liver, kidney, and spleen tissue were analyzed. Comet assay revealed low genotoxic potential,
while histological analysis and stereological investigation revealed no significant changes in exposed
animals when compared to controls, although the volume density of blood sinusoids and connective
tissue, as well as numerical density and number of mitosis were slightly increased. Additionally,
despite the significantly increased average number of the Ki67 and slightly increased number of
CD68 positive cells in the presence of ALBO-OS, immunoreactive cells proliferation was almost
neglected. Blood analyses showed that all of the blood parameters in rats fed with extract nanomaterial
are comparable with corresponding parameters of no feed rats, taken as blind probe. This study
contributes to the toxicological profiling of ALBO-OS scaffold for potential future application in bone
tissue engineering.
Keywords: hydroxyapatite; bone substitute; genotoxicity; subchronic toxicity; biocompatibility
1. Introduction
Increased number of skeletal system disorders, due to the increase of the human lifespan, imposes a
need for a new and more efficient bone healing procedure, since conventional treatments with auto-
and allografts have many drawbacks, such as infections, pain, long-term recovery, and rejection by a
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host immune system [1,2]. Tissue engineering, as an interdisciplinary approach integrating biology,
medicine, and engineering, offers an alternative by developing synthetic bone substitutes, which are
able to provide bone repair and regeneration, even at the large scale bone defects [1,3,4].
Biocompatible porous three-dimensional (3D) scaffolds that mimic the natural bone structure
have given the most promising results due to their biostimulative effect on cells proliferation and
neovascularization [1–5]. Besides, these scaffolds have to mimic bone in all biological aspects and
disintegrate at a rate that is similar to the new bone production to achieve the most efficient healing
treatment [6,7]. Among the wide range of biomaterials used for the synthesis of bone scaffolds [8],
hydroxyapatite [HAP, Ca10(PO4)6(OH)2] is one of the most widely utilized, since it possesses structural
and chemical similarity to natural bone. It is biocompatible, bioresorbable, and bioactive, and it enables
excellent cell adhesiveness [4,9–11].
The main drawbacks of HAP represent its lower rate of degradation in comparison to natural
bone, and its mechanical strength, which mostly depends on the microstructure. To overcome it,
HAP was modified due to available nanotechnology and widely combined with synthetic polymers.
These composite scaffolds exhibited better mechanical properties and bioactivity, in comparison to
ceramics or polymer alone [9,10,12]. Bearing all that in mind, novel porous bone substitute that is
based on nanostructured HAP covered with thin polymeric film of poly(lactide-co-glycolide) (PLGA)
has been synthesized recently and showed to present excellent biocompatibility through many in vitro
and in vivo investigations, as well as numerous superior characteristics in comparison to commercially
available product [13–15].
However, after being implanted in the tissue, the degradation process of the material in local tissue
occurs, and dissolved products obtain to systematic circulation. The chronical presence of scaffolds’
products in circulation could lead to toxicity, and this aspect of nanostructured HAP has been poorly
investigated so far.
Systemic subchronic toxicity studies, usually conducted in rodents by repeated administration of tested
compounds for more than 90 days (defined by the international standard ISO 10993: Biological evaluation
of medical devices), are necessary before clinical application of bone substitute, especially at the large
scale bone defects. A combined investigation of genotoxicity in vitro and systemic chronic toxicity could
provide new insights in safety evaluation and potential long-term adverse effects of investigated materials
and its leachable products [16].
The aim of this study was to provide toxicological profile based on in vitro genotoxicity and in vivo
systemic subchronic toxicity. A range of endpoints was evaluated, including biochemical analyses,
and histological and stereological measurements on liver, kidney, and spleen tissues, after 120 days of
oral administration. This study contributes valuable understanding of the novel three-dimensional
(3D) nanohydroxyapatite-PLGA scaffold (ALBO-OS) interaction on the systemic level to organism
under subchronic exposure scenario.
2. Materials and Methods
2.1. Test Material
A novel composite scaffold that was based on calcium hydroxyapatite and poly(lactide-co-glycolide)
(PLGA), named ALBO-OS, was used for in vivo toxicity study. The detailed procedure of material’s
synthesis and characterization is explained in our previous investigations [13–15], and a summary is given
in this paper.
Synthesis and Characterization
Briefly, HAP powder was hydrothermally synthesized from an approximately stoichiometric
mixture of calcium hydroxide (Ca(OH)2) and (NH4)2HPO4 (p.a. Merck KGaA, Darmstadt, Germany).
The obtained hydroxyapatite powder was further used for the production of HAP granules. Further,
ceramic slurry was made by mixing HAP granules and starch with water, and then poured over
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polyurethane foam with the required pore size distribution and dried at room temperature. Finally,
it was heated in an oven at 600 ◦C and sintered at 1200 ◦C for 4 h. The obtained porous HAP
compact was further disintegrated into 300 µm–1 mm granules. Finally, PLGA (Durect Corporation,
Birmingham, AL, USA, 50:50, M = 45,000–70,000) thin film was deposited onto the surface of HA
granules to obtain final product.
2.2. Genotoxicity Investigations In Vitro
2.2.1. Cell Exposure and Viability Evaluation
THP-1 cells were seeded in 12-well plates in concentration 15 × 104 cells per well. The next day cells
were exposed to ALBO-OS extract. Extract contained maximal concentrations of Ca2+ ions, which exact
value, was previously exactly ordered by ICP. The concentration corresponded to concentration of released
Ca2+ ions in saturated solution obtained after immersion of 0.05, 5, 10, and 50 mg/mL ALBO OS in
10 mL distilled water with previously adjusted pH at 7.37, during 120 h. For negative control, the cells
were not treated with material, while cells exposed to methyl methanesulfonate (MMS) solution (40 µM)
were used as a positive control. The cells were exposed to various treatments for 1 h, after which they
were centrifuged (200× g, 5 min.) and resuspended in Dulbecco’s phosphate-buffered saline (DPBS,
Sigma-Aldrich, Saint Louis, MO, USA). Prior to alkaline comet assay, Trypan blue exclusion assay [17]
was used for cell viability test. Cells’ viability evaluation was performed by microscopic observation
(AXIO Vert.A1; Carl Zeiss, Jena, Germany) at 400× magnification (with minimum 200 cells/sample).
2.2.2. Alkaline Comet Assay
The comet assay (single cell gel electrophoresis assay) was used to detect possible single- strand
DNA breaks, double-strand DNA breaks, alkali labile site, and incomplete excision repair sites [18].
The microscopic slides were pre-coated with 0.5% normal-melting point (NMP) agarose. Cells were mixed
with 1% low-melting point (LMP) agarose and then applied onto slides. After agarose solidification,
the additional layer of 1% LMP agarose was applied, and followed by the slides immersion for 60 min.
in alkaline lysis solution (1 M NaCl, 0.1 M EDTA, 10 mM Tris-HCl, 0.1% N-lauroylsarcosine, 1% Triton
X-100, 30 mM NaOH). The slides were further gently washed in distilled water, and immersed for 20 min.
in cold electrophoresis buffer (0.3 M NaOH, 1 mM EDTA, pH > 13), followed by the electrophoresis (30 min.
at 0.7 V/cm) in the same buffer. At the end of electrophoresis, the slides were neutralized with 0.4 M Tris-HCl
(pH 7.5) and stained with ethidium bromide (10 µg/mL). An epifluorescent microscope (Axio Imager.Z1;
Carl Zeiss, Jena, Germany) at 400× magnification was used for slides analysis. CometAssay software
(developed by Prof. Igor Kononenko research group, Laboratory for Cognitive Modeling, Faculty of
Computer and Information Science, University of Ljubljana) was used to analyze 50 randomly selected
comets per slide. As the DNA damage parameter, the percentage of DNA presence in the comet’s tail
(tail DNA (%)) was used. The measurements were done in three independent repeats.
2.3. Systemic Subchronic Toxicity Investigation
The Ethical Committee of the Faculty of Veterinary Medicine, University of Belgrade and Ministry
of Agriculture and Environment Protection of the Republic of Serbia approved the experimental
protocol (decision number 01-831/2), and realized in accordance with recommendations of European
Good Laboratory Practice (86/609 EEC) related to protection and use of laboratory animals.
2.3.1. Experimental Protocol
The investigation included 21 Wistar rats (Ratus norvegicus), at the age 8–12 weeks, and body
weight 240–260 g. Animals were placed in individual cages. During the experiment, the animals were
kept under following conditions: temperature 23 ± 3 ◦C, air humidity 55 ± 5%, 8–12 air changes/h,
and artificial lighting at intervals of 12 h day/night. The animals had free access to food and water.
The animal health status was monitored daily during the experiment.
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Extracts that were obtained after the highest concentration of ALBO OS, obtained during
5 days immersion of material (100 mg/mL) in distilled water (in accordance with the standard ISO
10993-12:2012—Biological evaluation of medical devices—Part 12: Sample preparation and reference
materials) was used for per oral rats feeding. After seven days of adaptation period, the animals
were randomly divided into experimental (n = 12) and control group (n = 9). To the animals in the
experimental group, 1 mL of ALBO-OS extract was per oral fed for 120 days, every day at the same time,
while, for the control group, distilled water was used. During the experiment, control of the health
status, behavior, changes in skin and haircut, food and water consummation, urination, and defecation,
was performed and recorded daily. The body weight of animals was checked after the adaptation
period, and afterward three times through the experiment.
2.3.2. Blood Analysis
At the end of the experiment, the blood samples were taken from lateral tail vein for hematological
(leukocytes, thrombocytes, hemoglobin) and biochemical analyses (alanine aminotransaminase (ALT),
aspartate aminotransaminase (AST), urea, creatinine, bilirubin, serum protein, glucose, and alkaline
phosphatase (ALP)).
2.4. Histological and Stereological Analysis
The animals were sacrificed by intravenous administration of thiopentone sodium solution
(170 mg/kg). The rats’ livers, kidneys, and spleens were removed, immersed in Buoin’s fixative solution
for 24 h, and, for better absorption, further cut into smaller pieces and then immersed into fresh Buoin’s
solution. Subsequently, all of the dissected organs were prepared for the light microscopy using the
standard tissue preparation procedure. Tissue was embedded in paraffin. Tissue sections of 5 µm
thickness were cut using rotary microtome (Leica rotary Microtome RM 2165, Leica Microsystems,
Wetzlar, Germany). Every fifth section was used for the analysis in order not to repeat the analyzed
structures. Tissue was stained with hematoxylin-eosin (H&E) (Merck KGaA, Darmstadt, Germany).
The qualitative analysis of the microscopic slides was performed while using the light microscope
(Leica DM8000 M with MEGA VIEW camera and software system for digital image transfer, Wetzlar,
Germany). For quantitative, stereological analysis, micrographs were acquired in the RGB layout and
converted to binary format. Measurements were made using a stereo-universal test system according to
Cavalier’s principle, while using 16.0 point-counting system (MBF software system Application Suite
3.0.0, MBF Bioscience, Williston, VT, USA), with P2 spacing grid at the maximum 400× magnification.
Stained tissue sections of liver, kidney, and spleen were used to measure the number and
volume density (Vv) of epithelial cells. Volume density was calculated through the following formula:
Vv = Pf/Pt (mm0), where Pf represents the number of the desired phase on the test system (epithelial
cells) and Pt represents the total number of points of the test system [19].
The following principle was used for the determination of the number of matches on the test
system: all of the endothelial cells’ nuclei were marked as reference point, while the cells surfaces
were calculated according to the principles: (i) all cells that have a clearly visible contour and nucleus,
(ii) the cells contour do not touch the test system frame, and (iii) the cells contour is clearly visible
without a visible nucleus. The numerical density (Nv) of all epithelial cells was calculated based on the
cell count (Q) in the volume of analyzed tissues (Vo). The volume of analyzed tissue was evaluated as
the product of the number of counted frames (ΣPi), the space of counted frame (a = 25,002), and the
height factor (h) (the histological section), as presented in the following formula [20]:
Nv =
Q
Vo
=
Q∑n
i=1 Pi× a× h
(mm−3) (1)
MBF software system was used to measure the surface and volume of epithelial cells and nuclei,
by the thickness of their diameters. Measuring the surface of epithelial cells and nuclei enabled the
measurement of the cells, cytoplasm, and nuclei volumes. The ratio between the cells’ nuclei and
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cytoplasm volumes was used to determine the nucleocytoplasmic ratio (NCO). The mitotic index
was determined as the ratio between the number of cells in mitosis and the total number of cells in
10 visible optical fields per slide, with maximum 200× magnification.
2.5. Immunohistochemical Analysis
For the immunohistochemical analysis, the paraffin tissue sections of rat liver, spleen, and kidney
were analyzed cut at 5 µm, and the slides were heated for 60 min. at 56 ◦C. Prior to the antigen retrieval
step, the sections were deparaffinized and rehydrated through the series of xylenes and alcohols.
To block endogenous peroxidase activity, tissue sections were treated with 3% H2O2 solution in PBS.
Tor epitope retrieval, tissue sections were heated in microwave oven for 21 min., at 680 W, in 10 mmol/L
citrate buffer, pH 6.0. The tissue sections were incubated with appropriate antibodies (against CD68
(RTU-CD68, Leica, LOT 6000698, Wetzlar, Germany) and Ki67 protein (Monoclonal Mouse Anti-human
Ki67 Antigen, Clone Ki-S5, Sigma-Aldrich, Saint Louis, MO, USA (dilution 1:100)) over night, at +4 ◦C,
in the humid chamber. Streptavidin-biotin technique was used for immunostaining (LSAB+/HRP Kit,
Peroxidase Labeling, K0690, DAKO Cytomation, Glostrup, Denmark). Immunoreactivity complex was
visualized with DAKO Liquid DAB+ Substrate/Chromogen System (Dako, CA, USA, Code No. K3468)
and then counterstained with Mayer’s hematoxylin (Merck, KGaA, Darmstadt, Germany). As negative
control served the tissue sections with omitted primary antibody. For positive control, the tissue
sections that were known to express CD68 and Ki67 were used. CD68 and Ki67 positive cells in tissues
were analyzed by a light microscope (Olympus AX70, Hamburg, Germany) with 40× magnification.
In all of analyzed sample of tissue, five hot spots were selected for image analysis in ImageJ
(The National Institutes of Health, Bethesda, MD, USA). Ki67 and CD68 expressions were calculated by
determining the positive Ki67/CD68 areas (brown-colored cells) in microscopic fields (40× magnification),
based on the threshold [21]. Median values of CD68 and Ki67 immunostaining were calculated for each
individual tissue sample and then used for further analysis.
2.6. Statistical Analyses
All of the values were presented as mean ± standard deviation. Group comparisons were
performed while using parametric (two-way ANOVA, one-way ANOVA followed by Dunnett’s test
and t-test) or nonparametric tests (Kruskal–Wallis and Mann–Whitney U-test), depending on data
distribution, with significance set at p < 0.05. Statistical software SPSS 20.0 (IBM corp., Armonk, NY,
USA) was used for data processing.
3. Results
3.1. Genotoxicity Results
The results of Trypan blue exclusion assay indicated that none of the nanoHAP-PLGA
concentrations (0.05, 5, 10, and 50 mg/mL) was cytotoxic to THP-1 cells after 1 h exposure. In all tested
samples, cell viability was over 90%. The results of the comet assay showed that none of the used
ALBO-OS concentrations was genotoxic to THP-1 cells (Figure 1).
There is no comet tail for any of material’s concentration, which means that there is no damaged
DNK (broken fragments) that would migrate from the “head” during the electrophoresis, like in the
case of positive control, as it can be seen in Figure 1B.
3.2. Systemic Subchronic Toxicity Results
3.2.1. Main Clinical Symptoms and Observations
During the course of the exposure, no adverse effects that were related to the behavior of the tested
animals were observed, as investigated at a daily level. No changes in skin and haircut, as well as
changes in food and water consummation, or urinating and defecation, have been reported. Body mass
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was measured four times during the experiment, and in all animals it was mildly and consistently
increased through the observation period (Figure 2).
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3.2.2. Results of Blood Analysis
The hemoglobin and thrombocytes values were fairly similar in the experimental and control
group. Significantly higher leukocyte values were found in the control group, p < 0.001 (Table 1).
Table 1. Results of blood analysis; values are shown as mean ± SD (*** p < 0.001; t-test).
ALBO-OS Control
Leucocytes 4.12 ± 1.94 6.83 ± 0.77 ***
Hemoglobin 144 ± 8.26 140.8 ± 6.76
Thrombocytes 566.56 ± 269.54 713.20 ± 181.58
In Table 2, the results of the analysis of the biochemical parameters are presented. No significant
differences were found for urea, creatinine, and bilirubin values. The ALT level and glucose were
slightly higher in the experimental group when compared to the control, while the AST level was
higher in the control versus the experimental group, all without significant differences. The alkaline
phosphatase values were higher in the experimental group, and this difference was highly statistically
significant (p < 0.003).
Table 2. Results of analysis of biochemical parameters; the values are shown as mean ± SD
(*** p < 0.001; t-test).
ALBO-OS Control
ALT 74.50 ± 23.07 71.50 ± 31.11
AST 630.50 ± 637.22 844.32 ± 838.57
Urea 5.68 ± 0.81 5.21 ± 0.36
Creatinine 42.30 ± 5.50 40.00 ± 4.84
Bilirubin 1.12 ± 0.51 1.01 ± 0.32
Glucose 6.23 ± 1.70 5.48 ± 0.99
ALP 81.50 ± 13.91 *** 63.00 ± 9.80
3.2.3. Histological and Stereological Analysis of the Liver Tissue
The morphology of the liver tissue (of animals orally exposed to ALBO-OS extract) was not
significantly different to the control. Hepatocytes and hepatic plaques were normal and neatly placed,
without abnormality in the form of a central vein. There were no pathological changes in liver tissue,
such as cysts, fibrosis, loss of hepatocytes, necrosis, or lymphocyte aggregates, due to inflammatory
reactions, in the experimental or in control group. Further histological and cytological analysis of liver
tissue was based on the comparison of fifteen stereological parameters (Table 3). The number and
numerical density (p < 0.05), and surface area of capillary endothelial cells (p < 0.05) increased in the
experimental group relative to control (Table 3 and Figure 3A).
The digital processing of the cross-section of the liver tissue in the RGB program revealed an
increase in the number, numerical density, and number of mitosis in treated group (Figure 3C).
The hepatocytes with two nuclei were revealed in experimental group (Figure 3B,D, red circles),
evidencing the higher number of mitosis, in comparison to the control. Although, the increase was not
statistically significant (p > 0.05) (Table 3).
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Table 3. Stereological parameters of the liver of the control and treated groups of rats; values are shown
as mean ± SD (* p < 0.05; t-test).
Parameter ALBO-OS Control
Volume density of hepatocytes (mm0) 0.681 ± 0.032 0.656 ± 0.045
Volume density of capillary sinusoids (mm0) 0.204 ± 0.008 0.163 ± 0.005
Volume density of connective tissue (mm0) 0.138 ± 0.004 0.126 ± 0.003
Number of hepatocytes 273,818.2 ± 24,146.0 255,168.4 ± 21,822.7
Numerical density of hepatocytes (mm−3) 47,887.4 ± 3119.6 44,575.3 ± 2632.9
Surface area of hepatocytes (µm2) 152.8 ± 4.1 148.5 ± 2.9
Surface area of hepatic nucleuses (µm2) 49.2 ± 1.9 46.8 ± 2.1
NCO of hepatocytes 0.383 ± 0.022 0.324 ± 0.023
Mitotic index of hepatocytes 1.77 ± 0.234 1.61 ± 0.24
Number of connective tissue cells 138,442.5 ± 16,443.4 127,486.1 ± 17,518.1
Numerical density of connective tissue cells (mm−3) 24,888.3 ± 3084.8 21,934.4 ± 2366.6
Surface area of connective tissue cells (µm2) 103.4 ± 2.4 99.6 ± 3.3
Number of capillary endothelial cells 328,132.2 ± 32,336.3 * 275,915.5 ± 29,079.0
Numerical density of capillary endothelial cells (mm−3) 53,714.3 ± 953.7 * 48,068.5 ± 2806.7
Surface area of capillary endothelial cells (µm2) 84.5 ± 4.6 75.1 ± 3.9
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3.2.4. Histological and Stereological Analysis of the Kidney Tissue
Histological analysis revealed no pathological changes in kidney tissue, such as the loss of cells
of collecting ducts, loss of glo eruli, cysts, fibrosis, necrosis, or lymphocyte aggregates and nodules.
Additionally, there as no infiltration of infla atory cells, infla mation or edema in glomeruli.
The volume densities f t e e it eli l cells of the collecting ducts, blood capillaries, connective tissue,
and glomeruli were higher in the treated group when compared to the control (Table 4 and Figure 4A),
with no statistic l ignifica ce. Th surface area of the epithelial cells, their nuclei, and the NCO ratio
did not change significantly in he experimental group, as compared to the control (p > 0.05, Table 4,
Figur B,C). Analysis regardi g conn ctive tissue and blood sinusoids showed their light change in
morphology (p > 0.05, Table 4, and Figure 4D). The surface area of glom ruli significantly decreased in
the experimental group relative to the control (p < 0.05), while the surface of Bowman’s space slightly
increased (Table 4 and Figure 4E).
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3.2.5. Histological and Stereological Analysis of the Spleen Tissue
Histological analysis revealed no pathological changes in the spleen tissue, such as change in the
morphology of the spleen tissue, loss of lymphocytes, cysts, fibrosis, loss of epithelial and radial cells,
necrosis, or large lymphocytes accumulation. Epithelial, endothelial, and connective tissue cells have
increased in their number, volume density, and numerical density in the treated group when compared
to control (Table 5, Figure 5A,B), mostly with no statistical significance, except for the number of
connective tissue cells (p < 0.05).
Table 4. Stereological parameters of kidneys of the control group and treated group of rats; values are
shown as mean ± SD (* p < 0.05; t-test).
Parameter ALBO-OS Control
Volume density of collecting ductus’ epithelial cells (mm0) 0.34 ± 0.04 0.33 ± 0.04
Volume density of blood sinusoids (mm0) 0.26 ± 0.03 0.23 ± 0.03
Volume density of connective tissue (mm0) 0.11 ± 0.01 0.10 ± 0.01
Volume density of glomeruli (mm0) 0.32 ± 0.04 0.30 ± 0.04
Number of collecting ducts’ epithelial cells 139,562 ± 1523 138,147 ± 3332
Numerical density of collecting ducts’ epithelial cells (mm−3) 20,107 ± 4116 19,572 ± 2621
Surface area of collecting ducts’ epithelial cells (µm2) 209 ± 43 204 ± 50
Surface area of collecting ducts’ epithelial cells nucleuses (µm2) 65 ± 3 63 ± 3
NCO of collecting ducts’ epithelial cells 0.28 ± 0.02 0.26 ± 0.03
Number of connective tissue cells 141,133 ± 18,097 134,698 ± 12,922
Numerical density of connective tissue cells (mm−3) 22,990 ± 2366 22,133.4 ± 2982.2
Surface area of connective tissue cells (µm2) 99 ± 11 102 ± 6
Number of capillary endothelial cells 306,126 ± 24,065 296,854 ± 26,658
Numerical density of capillary endothelial cells (mm−3) 39,141 ± 3342 37,645 ± 4459
Surface area of capillary endothelial cells (µm2) 77 ± 4 75 ± 4
Surface area of glomeruli (µm2) 3086 ± 415 4060 ± 535 *
Bowman’s space 49 ± 4 44 ± 4
Table 5. Stereological parameters of the spleen of the control group and treated group; values are
shown as mean ± SD (* p < 0.05; t-test).
Parameter ALBO-OS Control
Volume density of epithelial cells (mm0) 0.382 ± 0.036 0.359 ± 0.029
Volume density of lymphocytes (mm0) 0.409 ± 0.036 0.304 ± 0.058
Volume density of connective tissue (mm0) 0.119 ± 0.023 0.115 ± 0.025
Volume density of blood capillaries (mm0) 0.217 ± 0.04 0.167 ± 0.05
Number of epithelial cells 223,847.1 ± 27,129.8 204,568.3 ± 33,317.8
Numerical density of epithelial cells (mm−3) 37,498.5 ± 3318.7 35,641.8 ± 2625.9
Surface area of epithelial cells (µm2) 128.6 ± 2.7 131.5 ± 4.2
Surface area of epithelial cells’ nucleuses (µm2) 48.2 ± 5.3 41.2 ± 3.1
NCO of epithelial cells 0.274 ± 0.045 0.285 ± 0.052
Number of connective tissue cells 149,901.1 ± 6287.0 * 137,006.4 ± 8694.3
Numerical density of connective tissue cells (mm−3) 26,104.9 ± 2169.8 23,146.3 ± 2871.5
Surface area of connective tissue cells (µm2) 110.0 ± 4.6 105.6 ± 5.7
Number of capillary endothelial cells 241,697.6 ± 40,694.6 223,148.5 ± 20,204.4
Numerical density of capillary endothelial cells (mm−3) 39,905.4 ± 3588.8 34,969.4 ± 2599.3
Surface area of capillary endothelial cells (µm2) 78.6 ± 2.5 74.16 ± 2.3
Number of lymphocytes 432,527.8 ± 37,841.8 * 348,336.9 ± 23,324.7
Numerical density of lymphocytes (mm−3) 57,323.4 ± 2201.4 * 49,131.5 ± 3740.2
Surface area of lymphocytes (µm2) 97.2 ± 3.5 96.4 ± 4.9
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3.3.6. Expression of Proteins Ki67 and CD68 in Liver, Kidney, and Spleen 
The highest average number of Ki67 positive cells was detected in kidney experimental group, 
while the smallest number of Ki67 positive cells were detected in liver control group, which indicated 
that the proliferation ratio was different in all three investigated organs (Figure 6). According to our 
results, the highest average number of immunoreactive CD68 cells was detected in spleen tissue 
samples of experimental group, while the smallest average number of cells were detected in the liver 
tissue samples (Figure 7).  
Differences between the average number of Ki67 positive cells was significantly higher in kidney 
tissue samples of experimental group in comparison to control (p < 0.05). Additionally, the average 
number of Ki67 positive cells was detected in liver (p < 0.05) and spleen (p < 0.05) experimental groups 
in comparison to control (Figure 8A).  
The differences between the number of immunoreactive CD68 cells was not statistically 
significant in all three groups of investigated organs (Figure 8B). 
Figure 5. Micrographs of the histological cross-section of the rat spleen of the control (a) and treated
group (b), (H&E). (A) White arrows show connective tissue and red arrows show lymphatic tissue.
Magnification 200×; (B) White arrows show epithelial cells. Magnification 50×; (C) White arrows
show lymphocytes and red arrows show blood vessel. Magnification 50× and, (D) Red arrows show
lymphocytes. Magnification 50×; digitally processed RGB technique.
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The number and numerical density of lymphocytes in the experimental group were higher in
comparison to control (p < 0.05, Table 5, Figure 5C,D). A large number of mature lymphocytes in
sinusoids and between the star-shaped epithelial cells of the spleen were observed. Lymphocytes were
highly colored, uniformly distributed, with no signs of focal aggregations in tissue.
3.2.6. Expression of Proteins Ki67 and CD68 in Liver, Kidney, and Spleen
The highest average number of Ki67 positive cells was detected in kidney experimental group,
while the smallest number of Ki67 positive cells were detected in liver control group, which indicated
that the proliferation ratio was different in all three investigated organs (Figure 6). According to
our results, the highest average number of immunoreactive CD68 cells was detected in spleen tissue
samples of experimental group, while the smallest average number of cells were detected in the liver
tissue samples (Figure 7).Nanomaterials 2020, 10, x FOR PEER REVIEW 12 of 22 
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Differences between the average number of Ki67 positive cells was significantly higher in kidney
tissue samples of experimental group in comparison to control (p < 0.05). Additionally, the average
number of Ki67 positive cells was detected in liver (p < 0.05) and spleen (p < 0.05) experimental groups
in comparison to control (Figure 8A).
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Figure 8. Percentage area of Ki67 (A) and immunoreactive CD68+ (B) stained cells was calculated with
Imag J using 3 images per organ. The results were analyzed with a two-way ANOVA, a p value < 0.05
was considered significant; * p < 0.05.
The differences between the number of immunoreactive CD68 cells was not statistically significant
in all three groups of investigated organs (Figure 8B).
4. Discussion
This study aimed to characterize toxicological potential of ALBO OS scaffold by investigating
its potential genotoxicity in vitro and systemic subchronic toxicity after oral exposure, which is very
important for its potential application in dental medicine.
Genotoxicity investigation on THP-1 cells using comet assay showed the lack of damaged DNAs
in the cells that were cultivated in material’s extracts up to concentration 50 mg/mL which highly
suggests that there were no changes inside of the cells on the level of DNA. This is in accordance
with previous investigations that also reported low genotoxicity of hydroxyapatite and PLGA alone,
which are the main components of the ALBO-OS [22–24].
The blood analysis showed that there were no significant changes in the hematological parameters
between the experimental and control group. Neither myelotoxic nor autoimmune effects on peripheral
blood cells were detected in the experimental groups. This is in agreement with previous reports on
the low hazard of these material [13,25]. Among the analyzed biochemical parameters, only alkaline
phosphatase was significantly higher in the experimental group, compared to the control. This difference
indicated the potential of the absorption of calcium and phosphates from ALBO OS, which consequently
might led to an increase of ALP serum [26].
The results of histopathological examination of systemic toxicity on liver, kidney and spleen
sacrified rats after their oral exposure to extract of ALBO OS maximal concentration (100 mg/mL)
during 120 days per oral feeding were particularly important for the determination of the toxicological
profile ALBO OS.
Accordingly, the liver is chosen due to its vital role in organism being reflected by its physiological
functions, synthesis and detoxification of various metabolites. In other words, any lesions caused
by drugs, chemicals, and pathological status could interrupt its functions [27]. The ALT level,
which is found primarily in the liver, and is released into the circulation from damaged hepatocytes,
was slightly higher in the experimental group, while the AST level, found in the erythrocytes, myocytes,
and kidney cells also, was higher in the control, without significant differences [27]. Similar results of
biocompatibility investigation of Mg-Zn materials were reported, with the assertion that there was no
change in the hepatocyte architecture and morphology of liver lobules [28].
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The increased mitotic index and the number of hepatocytes with two nuclei could be explained by
the liver adaption to the presence of new material in the organism [29]. It could be assumed that, as a
reaction to chronical presence of ALBO OS extract in organism, the physiological reaction of increased
function occurred. It is interesting to note that immunostaining confirmed parenchymal proliferation
over increased expression value of the Ki67, while a number of immunoreactive CD68 positive cells
remained in the physiological range. The increase in Ki-67 protein expression might be caused by the
fact that posttranscriptional regulatory mechanisms suppress protein synthesis until the cells are at the
G1/S boundary playing a critical role in the regulation of mitosis. In this case, like too many similar
evidences published in other research papers, it seems that Ki67 is involved in the regulation of cell
cycle progression, including DNA replication, higher-order chromatin organization, etc. [30,31].
In our previous study, the effect of calcium silicate and calcium aluminate implantation on
systematic subchronic toxicity was evaluated [32]. It was concluded that materials induced normal
and reversible response in the liver. Namely, the proliferation of parenchymal cells in this case was also
reported, with no visible signs of pathological changes or immunological reaction to the materials [32].
An increase in the number and density of capillary endothelial cells (p < 0.05) (obtained as all other
histological and immunohistochemical parameters included in this paper, by observation 12 animals in
experimental group and nine animals in the control group) indicated a statistically significant increased
blood flow through the liver in experimental group, when comparing with control group of rats,
which is characteristic for processes with more intense blood filtration. Additionally, significant increase
the number of endothelial cells (p < 0.05) participating in the formation of new blood sinusoids was
observed, which indicated that the process of the necessary adaptation of the rats’ liver to ALBO-OS is
occurred. As it is well known, the liver sinusoidal endothelial cells (LSEC) constitute the sinusoidal
wall, or endothelial lining. Therefore, they can be observed as unique capillaries that differ from other
capillaries in the body, because of the presence of open pores or fenestrae lacking a diaphragm and a
basal lamina underneath the endothelium. The increasing quantity of the Ca2+ ions, interacting with
lipid soluble ionophores, which transport Ca2+ ions across liver cell membranes, can induce increased
transport Ca2+ ions inside of the liver sinusoidal endothelial cells, influencing their contraction and,
consequently blood flow diminishing through them. Therefore, the balance establishing in blood flow
through sinusoids, the new blood sinusoids should be formed, simultaneously leading to the increased
number of the endothelial cells [20,33–35]. The connective tissue cells, as stromal cells, did not change
their structure or density, suggesting no pathological change on liver tissue occurred during four
months of exposure. Similar to our results, in previous studies of systematic toxicity of new endodontic
materials that are based on calcium hydroxyapatite and calcium silicates, an increased mitotic activity
of parenchymal cells was observed and followed by the increased density of the cells and a moderate
increase in the liver sinusoids and hepatocyte surface [36,37].
The serum levels of creatinine, as an indicator of kidney function and the change of renal
histopathology [38], were very similar in the experimental and control group, as well as values of
urea and bilirubin. In the previous study, the absence of any morphological changes in the kidney
tissue due to the implantation of biocompatible Mg-Nd-Zn-Zr material into the bone of the rabbit was
reported [39], which is in accordance with the presented results.
The number of epithelial cells in collecting ducts and the connective tissue cells, as well as other
stereological and cytological parameters, were not significant (p > 0.05), while immunostaining revealed
significantly higher number of Ki67 positive cells, indicating cell proliferation in experimental group,
increased kidney activity, and blood flow. In the study of mineral trioxide aggregate effect on the liver
and kidney function, it was reported that the kidney function had subsequently increased after a month,
while the increased liver function was observed during the first week and further increased during the
observed period [29]. Glomeruli, the beneficial components of the kidneys influenced by all matter
in the blood reacted by shrinkage in the presence of material’s products, while its morphology was
preserved. Besides, the area of renal kidney glomeruli of rats (p < 0.05) was statistically significantly
reduced during the treatment by ALBO-OS, probably as a consequence of the increase of filtration
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blood flow into the them. Fray has developed a mathematical model suggesting the stretch-dependent
influx of extracellular calcium ions into juxtaglomerular cells to account for the pressure control of renin
secretion [40]. In detail, an increase of the renal artery pressure would enhance the circumferential
stretch of the juxtaglomerular cells, thereby causing membrane depolarization.
Therefore, a rise of the intracellular calcium concentration inhibits reining secretion from these
cells, as a consequence of the renal glomeruli shrinkage [29,41,42]. Additionally, the change was
reflected in the slight increase in the surface of Bowman’s space as a sign of increased glomerular
filtration. In our study, while the spleen retained a normal physiological architecture, the number of
lymphocytes increased in the treated rats, thus indicating an immune response to ALBO OS extract.
While proliferation of lymphocytes was induced by material during four months of oral administration,
lymphocytes were highly colored, uniformly distributed, with no signs of focal aggregations in
spleen tissue, suggesting mature lymphocytes were predominantly in the tissue, with no signs of
tissue hyperplasia.
Furthermore, number of CD68 positive immune cells in spleen was similar in the experimental
and control group. In previous investigations of systemic toxicity of new endodontic material based
on hydroxyapatite and calcium silicates, the slight hypertrophic changes in white pulp were reported,
with no adverse effect on the spleen function and its immune response activation [36]. Statistical analysis
showed a significant increase (p < 0.05) of the number of connective cells in the spleen of rats, during the
treatment with ALBO-OS, which is a consequence of the increased production of lymphocytes in the
spleen and their increased activity in the blood. Additionally, the increase of the number and numerical
density of lymphocytes in the spleen of rats during the treatment by ALBO OS was also statistically
significant (p < 0.05).
Calcium plays an essential role in the activation and maturation of lymphocytes. As a second
messenger, calcium ions are involved in most biochemical processes that transduce the external
signals into cell responses. An increase in Ca2+ ions and subsequent protein kinase C activation is
indispensable for T-lymphocyte proliferation and an increase of their number [43]. Previous studies
reported that increased Ca2+ ions promotes IL-2 mRNA gene expression and protein synthesis and that
IL-2 is a potent T-lymphocyte growth factor [28,44,45]. Since spleen primarily acts as the main filter
for blood-borne pathogens and antigens, an increased number of lymphocytes could be explained by
higher blood perfusion through spleen and the presence of the materials’ extract at high concentration
in organism during a prolonged time period [46]. Furthermore, haematological analysis revealed
no increase of lymphocytes in systematic circulation in the experimental group, which implied the
transient and physiological nature of increased spleen tissue lymphocytes.
An estimate of blood volume in the rat is 4.7 to 8.0 mL per 100 g body volume (BW) (mean value
7.0 mL) [47]. The BW in our case for all rats were 240–260 g, from which follows that blood quantity
following Lee and Blaufox research [47] was probably between 16.8–18.2 mL. Taking in mind that
all of the experimental rats were fed with 1 mL/day of fresh saturated solution of extract obtained
by immersion 100 mg/mL for 120 days, the total quantity of used extract for 120 days is 120 mL,
which is 6.6–7.1 times higher than the total volume of the blood of rats. Although this is exceptionally
high quantity of Ca2+ ions in rat’s blood, the pathological effect expressed over significant changes of
morphology of tissue of the liver, kidney, and spleen were not registered, suggesting that the used
nanomaterial is biocompatible.
5. Conclusions
The tested ALBO OS proved that it could immitate natural bone by its arhitecture and mechanical
properties, as well by the rate of resorption, as confirmed by our previous investigations of its structure
and physico mechanical characteristics briefly described in the Appendix A of this paper. In additon,
this material also showed low hazard potential, as determind by in vitro genotoxicity study and sistemic
toxicity study. Genotoxic study confirmed no genotoxic effect, even at the highest concentration of
the 50 mg ALBO OS/mL. Daily oral administration of ALBO OS extract extremely high concentration
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(100 mg/mL) through a prolonged time period (120 days of their per oral feeding) induced no adverse
and reversible response in rats’ liver, kidney, and spleen. Despite the significant increase average
number of the Ki67 suggesting cell proliferation, a slight increase in number of immunoreactive CD68
positive cells in the presence of ALBO OS, evidencing no difference in number of tissue immunoreactive
cells, although the proliferation of parenchymal and stromal tissue occurred. This study suggests the
good biocompatibility of novel nanostructured scaffold, which could serve as a suitable candidate for
future investigations generally in regenerative medicine.
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Appendix A.
Appendix A.1. Physicochemical Characterization of the Extract of the ALBO-OS Scaffolds
X-ray diffraction (XRD) performed phase analysis of HA using a Philips PW 1050 diffractometer
with Cu-Kα1–2 lamp. The data were collected in the 2θ range from 15–65◦, in steps of 5◦, and 2 s per
step time exposure.
The microstructure of the ALBO-OS scaffold was investigated by micro-computed tomography
(µCT) (SkyScan, Bruker 1172, Kontich, Belgium), and for the porosity analysis CTAn 1.14.4.1 software
(SkyScan, Bruker) was used.
For the analysis of porosity, a classical method, known as the liquid displacement method,
was also used. The absolute ethanol with density ρ was used as displacement liquid because of its
ability to easily penetrate into the scaffolds without inducing the shrinkage or swelling of the PLGA.
The samples, pycnometer, and ethanol were kept at 25 ◦C for 4 h prior to testing. A pycnometer
that was filled with ethanol was weighed, W1. A scaffold sample of weight WS was immersed into
the bottle full of ethanol, and the bottle was then slowly surged until the air in the scaffold was all
removed. At last, the pycnometer was refilled with ethanol and was weighed, W2. The scaffold
saturated with ethanol was taken out of the pycnometer and the pycnometer was weighed, W3.
The volume of the scaffold sample was calculated vs. = (W1 − W2 + WS)/ρ, as well as the total volume
of the pores: Vp = (W2 − W3 + WS)/ρ. The porosity of the sample can be calculated by using equation:
P = Vp/(Vp + Vs) = (W2 − W3 − WS)/(W1 − W3) [48].
Scanning electron microscopy (SEM) was used to analyze the material microstructure. For SEM
observations samples were fixated in gradient ethanol concentrations (10–100%) and coated with gold
by sputtering and JEOL JSM-5300 microscope was used.
In order to determine the rate of the decomposition/degradation of nanoHAP granules, they were
submerged in mixture of the medium of a phosphate buffer (PBS) and Tris buffer (tris (hydroxymethyl)
amino methane) in the ratio 1:1, with pH 7.37. The rate of degradation was determined as the
difference in the calcium ions concentrations in the medium during experiment in comparison to
starting concentration, and measured by inductively coupled plasma mass spectrometry (iCAP 6500
Duo ICP, Thermo Fisher Scientific, Inc. USA). For these purposes, aliquots of 3 mL of the medium were
taken. The measurement started 10 minutes after immersion of the granules into the mixed medium
and set according to the following schedule: 10 and 30 min., one, four, and eight hours, one, two, five,
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eight, 12, 15, 19, and 22 days. The obtained values are presented in the diagram depending on the
calcium ions concentration.
Compressive strength of the granules ALBO-OS was measured after various immersion times in
balanced salt Hanks solution (8 g NaCl, 0.35 g NaHCO3, 0.4 g KCl, 0.06 g KH2PO4, 0.1 g MgCl2 × 6H2O,
0.14 g CaCl2, 0.06 g Na2HPO4 × 2H2O, 0.06 g MgSO4 × 7H2O, 1 g glucose in 1000 mL of dH2O)
with initial pH value 7.4. The samples were immersed into 10 mL of solution at 37 ◦C following
the schedule. For the test of compressive strength, the porous compacts of nanoHAP were used,
with completely equivalent structure of the ALBO-OS granules, with the dimension of 16 × 16 × 10 mm.
For the measurement Instron model 4204 (Instron Corp., Canton, MA, USA) was used, with previous
preparation of the samples by polishing with 600 and 1200 grit sandpaper on an automated rotary
grinder, under gently running tap water, after which they were dried with adsorbent paper. The standard
deviation was determined by measuring strength of the 10 samples.
Appendix A.2. A Brief Review of ALBO-OS Structural and Physicochemical Characteristics
XRD revealed that the phase composition of the HA corresponds to carbonate calcium
hydroxyapatite Ca10(PO4)6(OH)2 (JCPDS 9–432). All characteristic diffraction peaks were present:
(002) at 25.98◦, (120) at 29.03◦, (121) at 31.87◦, (300) at 33.07◦, (310) at 39.94◦, (222) at 2θ, and (123) at
49.54◦ (Figure A1A).
Very high porosity of ALBO-OS compact was revealed by liquid displacement method and
particularly micro CT analysis (Figure A1B). The total porosity was 75.4%, which was also the value of
the open porosity. Additionally, a significantly high number of connected pores per mm3 was found,
13.6 in value. Micro CT show very wide pore distribution, as shown in the Table A1.
From the Table A1, it is visible that although the average pore volume is the smallest for radius
pore in the range 0.06 mm and 0.1 mm, its number is the highest (almost 2/3 total pore number). Most of
them are in the radius range less than 0.02 mm, (83.3% of total pore number). From the other side,
the number of pores with radius in the range higher than 0.4 mm is only about 5.4%.
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The SEM micrographs clearly showed that the obtained scaffolds had very porous three-
dimensional (3D) macrostructure (Figure S2). SEM examinations show a well-defined internal 
geometry, with fine pores of multimodal diameters, which is particularly visible in Figure S2B. The 
pores much higher than 5 µm and elongated grains sizes of 5–15 µm, can be noticed in the mean part 
of figure, while in the fragments given in the figure edges, very fine porosity can also be noticed, with 
elongated and spherical grains sizes order of the 120 nm in radius, being interconnected with 
surrounding grains, forming among them pores of similar radius (100 to 130 nm), and grains of mean 
diameters from 100 to 220 nm (clearly visible in the higher SEM magnification). The particles are 
i re A1. (A) pattern of A; (B) icro- sca of ano P-PLGA.
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Table A1. Values of ALBO-OS porosity.
Pore Sizes Total PoreVolume (%)
Thickness Distribution
of the Scaffold Inner
Walls (%)
Number of Pores with
Average Radius in the
Given Range
Pores of Average Radius
in the Given Range in
Total Number of Pores (%)
0.06 mm–0.1 mm 2.52 8.90 9333 61.6
0.1 mm–0.2 mm 5.60 64.42 3294 21.7
0.2 mm–0.3 mm 5.83 26.68 737 4.8
0.3 mm–0.4 mm 11.66 / 971 6.4
0.4 mm–0.5 mm 17.44 / 379 2.5
0.5 mm–0.6 mm 18.18 / 216 1.4
0.6 mm–0.7 mm 16.96 / 119 0.8
0.7 mm–0.8 mm 15.06 / 72 0.5
More than 0.8
mm 6.75 / 25 0.2
The SEM micrographs clearly showed that the obtained scaffolds had very porous
three-dimensional (3D) macrostructure (Figure A2). SEM examinations show a well-defined internal
geometry, with fine pores of multimodal diameters, which is particularly visible in Figure A2B.
The pores much higher than 5 µm and elongated grains sizes of 5–15 µm, can be noticed in the mean
part of figure, while in the fragments given in the figure edges, very fine porosity can also be noticed,
with elongated and spherical grains sizes order of the 120 nm in radius, being interconnected with
surrounding grains, forming among them pores of similar radius (100 to 130 nm), and grains of mean
diameters from 100 to 220 nm (clearly visible in the higher SEM magnification). The particles are
mostly of polygonal shape, being mutually interconnected into clusters with pores in their centers and
edges, forming characteristic micro- and nano-patterns.
Appendix A.2.1. Rate of ALBO-OS Degradation
Figure A2 provides the obtained results of the rate of degradation of the ALBO-OS. From the
concentration of the calcium ions in saturated part od the solubility curve, the solubility product was
determined. The obtained value of 7.85 · 10−44 was very close to the product solubility of biological
apatite (3.51 · 10−43) (Figure A2C).
The rate of ALBO-OS degradation was examined during prolonged-time period (0–428 h), as it
is shown in histogram in Figure A2D. Changes of the solubility rate as a change of concentration of
calcium ions in the time unit show that in static system the rate of solubility is the extremely high for
initial 8 h measured (0.024 mg/l·h), while, after 120 h, it significantly decreases (0.001 mg/l·h). It can be
noticed that the peak of calcium ion release is present during first five days of immersion. Finally after
528 h it is almost neglectable (7.4 · 10−6 mg/l·h), similarly to the biological apatite.
Appendix A.2.2. Change of Compressive Strength during ALBO-OS Degradation
During six weeks of ALBO-OS immersion in Hanks solution, which has a composition close to
the composition of body fluids, it can be noticed that compressive strength is changed from 15.5 MPa
to 7 MPa. Further changes between 13 and 26 weeks were relatively low (Figure A2E).
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